Quest Diagnostics Long-Term Investments 2010-2024 | DGX
Quest Diagnostics long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Quest Diagnostics long-term investments for the quarter ending September 30, 2024 were $0.125B, a 3.85% decline year-over-year.
- Quest Diagnostics long-term investments for 2023 were $0.135B, a 2.27% increase from 2022.
- Quest Diagnostics long-term investments for 2022 were $0.132B, a 6.38% decline from 2021.
- Quest Diagnostics long-term investments for 2021 were $0.141B, a 72.94% decline from 2020.
Quest Diagnostics Annual Long-Term Investments
(Millions of US $) |
| 2023 |
$135 |
| 2022 |
$132 |
| 2021 |
$141 |
| 2020 |
$521 |
| 2019 |
$482 |
| 2018 |
$436 |
| 2017 |
$462 |
| 2016 |
$443 |
| 2015 |
$473 |
| 2014 |
$46 |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Quest Diagnostics Quarterly Long-Term Investments
(Millions of US $) |
| 2024-09-30 |
$125 |
| 2024-06-30 |
$126 |
| 2024-03-31 |
$133 |
| 2023-12-31 |
$135 |
| 2023-09-30 |
$130 |
| 2023-06-30 |
$135 |
| 2023-03-31 |
$128 |
| 2022-12-31 |
$132 |
| 2022-09-30 |
$138 |
| 2022-06-30 |
$147 |
| 2022-03-31 |
$155 |
| 2021-12-31 |
$141 |
| 2021-09-30 |
$124 |
| 2021-06-30 |
$111 |
| 2021-03-31 |
$527 |
| 2020-12-31 |
$521 |
| 2020-09-30 |
$480 |
| 2020-06-30 |
$495 |
| 2020-03-31 |
$496 |
| 2019-12-31 |
$482 |
| 2019-09-30 |
$474 |
| 2019-06-30 |
$458 |
| 2019-03-31 |
$454 |
| 2018-12-31 |
$436 |
| 2018-09-30 |
$456 |
| 2018-06-30 |
$456 |
| 2018-03-31 |
$474 |
| 2017-12-31 |
$462 |
| 2017-09-30 |
$459 |
| 2017-06-30 |
$451 |
| 2017-03-31 |
$443 |
| 2016-12-31 |
$443 |
| 2016-09-30 |
$452 |
| 2016-06-30 |
$453 |
| 2016-03-31 |
$471 |
| 2015-12-31 |
$473 |
| 2015-09-30 |
$478 |
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
$46 |
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$18.293B |
$9.252B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
